Paying users zone. Data is covered by .
Get to Gilead Sciences Inc. for $17.99, or
get to whole website for at least 3 months from $49.99.
Price to FCFE (P/FCFE)
Free Cash Flow to Equity (FCFE)
Gilead Sciences Inc., FCFE calculation
USD $ in millions
|FCFE||Free cash flow to equity is the cash flow available to Gilead Sciences Inc.'s equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made.||Gilead Sciences Inc.'s FCFE declined from 2015 to 2016 and from 2016 to 2017.|
Price to FCFE Ratio, Current
Gilead Sciences Inc., current P/FCFE calculation, comparison to benchmarks
|No. shares of common stock outstanding|
|Selected Financial Data (USD $)|
|Free cash flow to equity (FCFE) (in millions)|
|FCFE per share|
|Current share price (P)|
|Bristol-Myers Squibb Co.|
|Eli Lilly & Co.|
|Johnson & Johnson|
|Merck & Co. Inc.|
|Regeneron Pharmaceuticals Inc.|
|Pharmaceuticals & Biotechnology|
If company P/FCFE is lower then the P/FCFE of benchmark then company is relatively undervalued.
Otherwise, if company P/FCFE is higher then the P/FCFE of benchmark then company is relatively overvalued.
Price to FCFE Ratio, Historical
Gilead Sciences Inc., historical P/FCFE calculation, comparison to benchmarks
1 Data adjusted for splits and stock dividends.
3 Close price on the filing date of Gilead Sciences Inc.'s Annual Report.
4 FCFE per share = FCFE ÷ No. shares of common stock outstanding
= ÷ =
5 P/FCFE = Share price ÷ FCFE per share
= ÷ =
|P/FCFE||Price to free cash flow to equity is cash valuation indicator of stockholders' equity.||Gilead Sciences Inc.'s P/FCFE ratio increased from 2015 to 2016 and from 2016 to 2017.|